Psoriasis and Skin striae
Summary:
Skin striae is found among people with Psoriasis, especially for people who are female, 60+ old.
The study analyzes which people have Skin striae with Psoriasis. It is created by eHealthMe based on reports of 59 people who have Psoriasis from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.
What is Psoriasis?
Psoriasis (immune-mediated disease that affects the skin) is found to be associated with 1,478 drugs and 1,694 conditions by eHealthMe. Check the latest studies of Psoriasis.
What is Skin striae?
Skin striae (irregular areas of skin that look like bands, stripes, or lines) is found to be associated with 193 drugs and 345 conditions by eHealthMe. Check the latest studies of Skin striae.
59 people who have Psoriasis and Skin Striae are studied.

Gender of people who have Psoriasis and experienced Skin Striae *:
- female: 67.92 %
- male: 32.08 %
Age of people who have Psoriasis and experienced Skin Striae *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 16.28 %
- 20-29: 25.58 %
- 30-39: 9.3 %
- 40-49: 11.63 %
- 50-59: 6.98 %
- 60+: 30.23 %
Common co-existing conditions for these people *:
- Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 13 people, 22.03%
- Rashes (redness): 2 people, 3.39%
- Depression: 2 people, 3.39%
- Weakness: 1 person, 1.69%
- Thyroid Diseases: 1 person, 1.69%
- Swelling: 1 person, 1.69%
- Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 1 person, 1.69%
- Pain: 1 person, 1.69%
- Joint Swelling: 1 person, 1.69%
- Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 1 person, 1.69%
Common drugs taken by these people *:
- Humira: 21 people, 35.59%
- Enbrel: 13 people, 22.03%
- Diclofenac: 12 people, 20.34%
- Movicol: 12 people, 20.34%
- Fragmin: 12 people, 20.34%
- Calcium: 10 people, 16.95%
- Methotrexate: 3 people, 5.08%
- Acitretin: 3 people, 5.08%
- Leflunomide: 3 people, 5.08%
- Taclonex: 2 people, 3.39%
Common symptoms for these people *:
- Fatigue (feeling of tiredness): 16 people, 27.12%
- Weakness: 16 people, 27.12%
- Dry Skin: 15 people, 25.42%
- Gastric Ulcer (stomach ulcer): 14 people, 23.73%
- Muscle Spasms (muscle contraction): 13 people, 22.03%
- High Blood Pressure: 13 people, 22.03%
- Gastrointestinal Tract Adenoma (a benign tumour (-oma) of glandular origin in digestive tract): 12 people, 20.34%
- Gastric Antral Vascular Ectasia (blood vessels in the lining of the stomach become fragile and become prone to rupture and bleeding): 12 people, 20.34%
- Gastritis (inflammation of stomach): 12 people, 20.34%
- Gastritis Erosive (a break in the surface layer of the membrane lining the stomach with infection): 12 people, 20.34%
* Approximation only. Some reports may have incomplete information.
Do you take medications and have Skin striae?
- Check whether Skin striae is associated with a drug or a conditionRelated publications that referenced our studies
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
- Mohagheghi MA, Omranipur R, Ensani F, Ghannadan A, Shahriaran S, Samiee F, Sedighi Z, "A Case of Advanced Unicentric Retroperitoneal Castleman's Disease, Associated With Psoriasis", Acta Medica Iranica, 2017 May .
- Chiriac A, Brzezinski P, Stolnicu S, Podoleanu C, Moldovan C, Molnar C, Taranu T, "Eosinophilia–A rare possible adverse reaction during anti-tumor necrosis factor-alpha therapy for psoriasis", Journal of Dermatological Treatment, 2016 Mar .
- Malisiewicz B, Murer C, Schmid JP, French LE, Schmid-Grendelmeier P, Navarini AA, "Eosinophilia during psoriasis treatment with TNF antagonists", Dermatology, 2013 Jan .
Related studies:
Treatments, associated drugs and conditions:
- Psoriasis (508,164 reports)
- Skin striae (1,640 reports)
All the drugs that are associated with Skin striae:
- Skin striae (193 drugs)
All the conditions that are associated with Skin striae:
- Skin striae (345 conditions)
How the study uses the data?
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
The study is based on Skin striae and Psoriasis, and their synonyms.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Chemotherapy and drugs of ingredients of ambrisentan - 7 seconds ago
- Drug interactions of Daybue and Ibu - 10 seconds ago
- Could Trodelvy cause Itching? - 17 seconds ago
- Could Percocet cause Menstrual Disorder? - 19 seconds ago
- Maternal Exposure During Pregnancy and drugs of ingredients of tocopherols and tocotrienols - 27 seconds ago
- Could Nasonex cause Type 1 Diabetes? - 35 seconds ago
- Multiple Sclerosis and drugs of ingredients of drospirenone; ethinyl estradiol - 37 seconds ago
- Could Prohance cause Vertigo Aggravated? - 41 seconds ago
- Drug interactions of Galantamine Hydrobromide and Depakote - 43 seconds ago
- Drug interactions of Xifaxan and Gemfibrozil - 47 seconds ago